EKSO

NASDAQ

Ekso Bionics Holdings Inc.

SectorIndustrialsIndustryIndustrial Machinery/Components

News25/Ratings0

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.

News · 26 weeks39-25%

2025-10-262026-04-19

Mix1690d

Insider7(44%)
Other5(31%)
SEC Filings4(25%)

Latest news

25 items

13dSEC
Amendment: SEC Form 10-K/A filed by Ekso Bionics Holdings Inc.
10-K/A - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
20dSEC
SEC Form DEF 14C filed by Ekso Bionics Holdings Inc.
DEF 14C - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
24dSEC
SEC Form PRER14C filed by Ekso Bionics Holdings Inc.
PRER14C - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
34dINSIDER
SEC Form 4 filed by Jones Jason C
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
34dINSIDER
SEC Form 4 filed by Wong Jerome
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
34dSEC
SEC Form PREM14C filed by Ekso Bionics Holdings Inc.
PREM14C - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
35dSEC
SEC Form SCHEDULE 13G filed by Ekso Bionics Holdings Inc.
SCHEDULE 13G - EKSO BIONICS HOLDINGS, INC. (0001549084) (Subject)
59dSEC
SEC Form 10-K filed by Ekso Bionics Holdings Inc.
10-K - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
62dINSIDER
Large owner Asher Daniel bought $191,162 worth of shares (15,540 units at $12.30) (SEC Form 4)
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
62dINSIDER
Amendment: New insider Asher Daniel claimed ownership of 316,663 shares (SEC Form 3)
3/A - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
63dINSIDER
Large owner Asher Daniel bought $11,520 worth of shares (1,200 units at $9.60) (SEC Form 4)
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
65dINSIDER
Large owner Asher Daniel bought $970,069 worth of shares (102,029 units at $9.51) (SEC Form 4)
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
65dSEC
Ekso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Financial Statements and Exhibits
8-K - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
65dSEC
SEC Form DEFA14A filed by Ekso Bionics Holdings Inc.
DEFA14A - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
77dINSIDER
New insider Asher Daniel claimed ownership of 321,763 shares (SEC Form 3)
3 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
84dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Ekso Bionics Holdings Inc.
SCHEDULE 13G/A - EKSO BIONICS HOLDINGS, INC. (0001549084) (Subject)
91dSEC
Ekso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
92dPR
Ekso Bionics Prices $5.852 million Private Placement
SAN RAFAEL, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the "Company") (NASDAQ:EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on January 20, 2026 it entered into securities purchase agreements with certain institutional and accredited investors for the purchase and sale of an aggregate of 5,852 shares of the Company's Series B Preferred Stock (the "Preferred Stock") and warrants (the "Warrants") to purchase up to an aggregate of 355,960 shares of common stock of the Company in a private placement transaction (the "Private Placement"). The shares of Preferred Stock will have a stated value of $1,000 per share and b
105dSEC
SEC Form SCHEDULE 13G filed by Ekso Bionics Holdings Inc.
SCHEDULE 13G - EKSO BIONICS HOLDINGS, INC. (0001549084) (Subject)
106dINSIDER
Chief Operating Officer Jones Jason C sold $12,210 worth of shares (1,320 units at $9.25), decreasing direct ownership by 5% to 25,621 units (SEC Form 4)
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
115dSEC
Ekso Bionics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
115dPR
Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale
DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ:APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, and EKSO Bionics Holdings, Inc. (NASDAQ:EKSO) ("EKSO") announced today that Applied Digital and EKSO entered into a non-binding term sheet for a proposed business combination of Applied Digital's cloud computing business, Applied Digital Cloud, with EKSO, which, once closed, will go forward as ChronoScale Corporation, an accelerated compute platform purpose-built to support artificial intelligence ("AI") workloads (the "Proposed Tran
134dINSIDER
Chief Operating Officer Jones Jason C sold $1,269 worth of shares (270 units at $4.70), decreasing direct ownership by 0.99% to 26,941 units (SEC Form 4)
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
134dINSIDER
Chief Financial Officer Wong Jerome sold $5,819 worth of shares (1,238 units at $4.70), decreasing direct ownership by 5% to 24,771 units (SEC Form 4)
4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
140dPR
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System
SAN RAFAEL, Calif. and TNUVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has entered into an agreement with Israel-based MediTouch Inc. ("MediTouch") to become the exclusive authorized sales agent and distributor of MediTouch's BalanceTutor™ rehabilitation system in the United States. The BalanceTutor is the only known rehabilitation system that employs an advanced 4D perturbation patented treadmill and multiple force and movement sensors which allow patients impacted by impaired balance to react to unanticipated